Other Stories

Full Video

SK Bioscience to conduct phase 3 clinical trial of its COVID-19 vaccine candidate Updated: 2021-08-30 21:05:00 KST

South Korean drugmaker SK Bioscience says it has begun the third phase of its COVID-19 vaccine candidate clinical trial becoming the country's first homegrown vaccine candidate to enter the final phase.
The company said on Monday that it will conduct trials to around 4-thousand adults, in 14 medical facilities in Korea and some other facilities overseas.
This comes nearly three weeks after the country's drug ministry approved the final stage of trial.
Within the first half of next year, SK Bioscience aims to produce an interim report before seeking final approval.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.